Inhibition of the lymphotoxin pathway as a therapy for autoimmune disease
- 1 June 2008
- journal article
- review article
- Published by Wiley in Immunological Reviews
- Vol. 223 (1), 202-220
- https://doi.org/10.1111/j.1600-065x.2008.00633.x
Abstract
The lymphotoxin (LT) system is part of the tumor necrosis factor family and is required for lymph node development. It has provided a wonderful tool for the dissection of processes critical not only for lymphoid organ development but also the maintenance of the adult immune architecture and the formation of ectopic organized lymphoid tissues in chronically inflamed sites. A soluble lymphotoxin-beta receptor-immunoglobulin (LTbetaR-Ig) fusion protein can block this pathway and is currently being tested in the treatment of autoimmune disease. This review focuses on the immunological consequences of combined LT and LIGHT inhibition with LTbetaR-Ig administration as distinct from the developmental biology.Keywords
This publication has 161 references indexed in Scilit:
- Lymphotoxin-Mediated Crosstalk between B Cells and Splenic Stroma Promotes the Initial Type I Interferon Response to CytomegalovirusCell Host & Microbe, 2008
- Follicular shuttling of marginal zone B cells facilitates antigen transportNature Immunology, 2007
- The potential utility of B cell-directed biologic therapy in autoimmune diseasesRheumatology International, 2007
- Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cellsNature, 2007
- Germinal-Center Organization and Cellular DynamicsImmunity, 2007
- Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cellsNature Immunology, 2007
- LIGHT Signals Directly to Intestinal Epithelia to Cause Barrier Dysfunction via Cytoskeletal and Endocytic MechanismsGastroenterology, 2007
- Lymphotoxin β receptor signaling is required for inflammatory lymphangiogenesis in the thyroidProceedings of the National Academy of Sciences of the United States of America, 2007
- Regulation of lymph node vascular growth by dendritic cellsThe Journal of Experimental Medicine, 2006
- NALT- versus PEYER'S-patch-mediated mucosal immunityNature Reviews Immunology, 2004